Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like ContraVir Announces Pricing Of Public Offering Of Common Stock And Warrants April 24, 2017 Maetrics Launches NEW Training Courses For 2017 February 16, 2017 Cambridge Startup Inozyme Nabs $49M and a Roster Packed With Seasoned Vets November 14, 2017
